Search

Search Constraints

You searched for: Author/Creator Yu, Mengxia

Search Results

2. Abivertinib, a novel BTK inhibitor: Anti-Leukemia effects and synergistic efficacy with homoharringtonine in acute myeloid leukemia. (1st October 2019)

9. Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation. Issue 1 (December 2017)